Immunohistochemistry Newsletters

Immunohistochemistry Newsletter

Rodney T. Miller, M.D.

Director of Immunohistochemistry

ProPath Laboratory

July 2007	Immunohistochemistry in the diagnosis of Lyme Disease
June 2007	Phospho-STAT5 Immunostains as a Surrogate Marker for JAK2 V617F Mutations in non-CML Chronic Myeloproliferative Disorders
May 2007	TLE1 Immunostains in the Diagnosis of Synovial Sarcoma
Apr 2007	PAX-5
Mar 2007	The Role of Immunohistochemistry for ERCC1 in Determining Therapeutic Response in Non-Small Cell Lung Carcinomas
Feb 2007	Immunohistochemistry in the Diagnosis of Whipple's Disease
Jan 2007	Update on Immunohistochemistry of Germ Cell Tumors
Dec 2005	MDM2 and CDK 4 immunostains in the diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma
Nov 2005	Annexin A1: A New Marker for Hairy Cell Leukemia
Oct 2005	Utility of immunostains for D2-40 in diagnostic pathology
Sept 2005	Immunohistochemical markers of prostate carcinoma, including prostate-specific membrane antigen (PSMA)
Aug 2005	Platelet derived growth factor receptor alpha (PDGFR-α) immunostains in the identification of c-kit negative gastrointestinal stromal tumors (GISTs)
July 2005	Immunohistochemistry in the Recognition of “Basal-like” or “Basaloid” Breast Carcinoma
June 2005	Immunohistochemical Features of Squamous Differentiation
May 2005	Immunohistochemistry in the recognition of respiratory syncytial virus (RSV) pneumonia
Apr 2005	Immunohistochemistry in the differential diagnosis of clear cell carcinomas from the kidney, liver, and lung
Mar 2005	Immunohistochemistry in dermatofibrosarcoma protuberans (DFSP) vs. dermatofibroma-fibrous histiocytoma (DF-FH)
Feb 2005	Ki-67 clone K-2: A useful marker of fat cells and lipoblasts
Jan 2005	Cytopathology-from an Immunohistochemist's Perspective
Dec 2004	Immunohistochemistry in the Differential Diagnosis of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Nov 2004	Immunohistochemistry in the Recognition of Early Myocardial Infarction
Oct 2004	Immunohistochemistry in the Differential Diagnosis of Schwannoma and Neurofibroma
Sep 2004	Immunohistochemistry in Amyloidosis
Aug 2004	Differential Diagnosis of Cytokeratin "Dots"
Jul 2004	Immunostains for B-catenin in Diagnostic Pathology
Jun 2004	Using fluorescent in situ hybridization (UroVysion FISH) for monitoring of recurrence of urothelial carcinoma
May 2004	Oct 3/4: A New Marker of Embryonal Carcinoma and Seminoma
Apr 2004	p63/P504S Antibody Cocktail in Prostate Biopsies
Mar 2004	Epidermal Growth Factor Receptor and Erbitux
Feb 2004	Perivascular Epithelioid Cell Tumors (PE Comas)
Jan 2004	Endogenous Biotin Artifact
Dec 2003	ZAP-70 in Chronic Lymphocytic Leukemia
Nov 2003	Cytokeratin AE1/AE3
Oct 2003	Immunohistochemistry in the Evaluation of Follicular or Nodular Lymphoid Lesions
Sep 2003	Immunohistochemistry in Lymph Node Histiocytosis
Aug 2003	Immunohistochemistry in the Evaluation of Atypical Epithelial Cells in Effusions
Jul 2003	TFE3 Immunostains in the Diagnosis of Alveolar Soft Part Sarcoma and Other Tumors
Jun 2003	Immunohistochemistry in Urothelial Dysplasia
May 2003	Anaplastic Lymphoma Kinase (ALK)
Apr 2003	Endocervical vs. Endometrial Adenocarcinoma: Update on Useful Immunohistochemical Markers
Mar 2003	Evaluation of Hydropic Placentas (Hydropic Degeneration vs. Partial Mole vs. Complete Mole)
Feb 2003	Calretinin
Jan 2003	Immunohistochemistry in Forensic Pathology
Dec 2002	CDX2
Nov 2002	P504S
Oct 2002	Utility of Ki-67 (MIB-1) Immunostaining in Cervical Biopsies
Sep 2002	Utility of p16 (INK4a) Immunostaining in Cervical Biopsies
Aug 2002	Ubiquitin Immunohistochemistry in Alzheimer's Disease
Jul 2002	Breast Carcinoma vs. Pulmonary Adenocarcinoma
Jun 2002	Human Herpesvirus Type 8 (HHV8)
May 2002	High Molecular Weight Cytokeratin (34ßE12)
Apr 2002	Optimal Titering of Primary Antibodies (And the Dangerous Fallacy of "Predilute Ready-to-Use" Antibodies)
Mar 2002	Tissue Protection Immunohistochemistry
Feb 2002	Recognition of Gluten Sensitivity
Jan 2002	Endocervical vs. Endometrial Adenocarcinoma
Dec 2001	True Positive vs. False Positive Staining
Nov 2001	Traps in Sentinel Lymph Node Biopsies
Oct 2001	Wilms Tumor Gene Protein (WT1)
Sep 2001	p63
Aug 2001	CD56 (NCAM)
Jul 2001	BCL-2
Jun 2001	Villin
May 2001	CD10
Apr 2001	Thyroid Transcription Factor-1 (TTF-1)
Mar 2001	Poorly Differentiated Prostate Adenocarcinoma Vs. Urothelial Carcinoma
Feb 2001	Immunophenotype of Renal Cell Carcinoma, "Clear Cell" Type
Jan 2001	hMLH1 and hMSH2: Important Immunohistochemical Markers for the Evaluation of Patients with Possible Hereditary Non-Polyposis Colon Cancer Syndrome
Dec 2000	Cytokeratin 5/6
Nov 2000	Gastrointestinal Stromal Tumors (GIST)
Oct 2000	Squamous Carcinoma vs. Poorly Differentiated GI Adenocarcinoma vs. Small Cell Carcinoma
Sep 2000	Antibodies Useful in the Diagnosis of Cutaneous Paget's Disease
Aug 2000	E-Cadherin: An Aid in Distinguishing Ductal from Lobular Breast Proliferations
Jul 2000	Myoepithelial Markers: An Aid in the Interpretation of Breast Biopsies
Jun 2000	Cat Scratch Disease Antibody Now Available

We are very grateful for Dr. Rodney T. Miller generous contribution of his newsletters. Please visit http://www.propathlab.com for more information and updates.